A Randomized Controlled Trial Evaluating an Online Intervention in Increasing Seasonal Influenza Vaccination Among Community Dwelling People Aged ≥65 Years
NCT05155241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 396
Last updated 2023-03-07
Summary
A non-blinded two-arm parallel randomized controlled trial will be conducted. Inclusion criteria are: 1) aged ≥65 years, 2) having Hong Kong ID, 3) Chinese speaking, 4) willing to be followed up by telephone, 5) having a smartphone, and 6) have not received SIV for the incoming flu season. Exclusion criteria include: 1) cognitive impairment, blindness or deafness, 2) not able to communicate with others effectively, and 3) with known contradictions of SIV (allergic to previous SIV, diagnosed/suspected egg allergy, with bleeding disorder or on warfarin). A total of 396 participants will be randomly assigned to either the intervention group (n=198) or the control group (n=198). Intervention group will watch an online health promotion video tailored to their current stage of change related to SIV uptake once every two weeks for four times (at week 0, 2, 4, and 6).
Participants in the control group will watch a same online video providing general advices related to SIV at week 0, 2, 4, and 6. All participants will be followed up by telephone 3 and 6 months after the baseline survey.
Conditions
- Vaccination Refusal
Interventions
- BEHAVIORAL
-
online health promotion video
Participants will watch an online health promotion video tailored to their current stage of change related to seasonal influenza vaccination uptake once every two weeks for four times (at week 0, 2, 4, and 6)
- BEHAVIORAL
-
Control (same online health promotion video)
Participants will watch a same online video providing general advices related to seasonal influenza vaccination at week 0, 2, 4, and 6
Sponsors & Collaborators
-
Chinese University of Hong Kong
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-12-01
- Primary Completion
- 2022-07-30
- Completion
- 2022-07-30
Countries
- Hong Kong
Study Locations
More Related Trials
-
Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong
NCT03330132 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccine Chatbot for Improving Influenza Vaccination Uptake
NCT06657573 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Direct and Indirect Benefits of Influenza Vaccination in Schools and Households
NCT00981513 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Trial Evaluating Safety and Immunogenicity of an Adjuvanted and a Conventional Influenza Vaccine in Elderly Subjects (> 60 Years)
NCT00310648 ·Status: COMPLETED ·Phase: PHASE3
-
Childhood Influenza Immunisation in General Practice Invitation Trial
NCT02921633 ·Status: COMPLETED ·Phase: NA
-
Mood and Influenza Vaccine Response: A Feasibility Trial
NCT03144518 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults
NCT01967368 ·Status: UNKNOWN ·Phase: PHASE4
-
Safety, Tolerability, Efficacy and Immunogenicity of an Influenza A Vaccine (FP-01.1) in Healthy Volunteers Following Virus Challenge
NCT02071329 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Impact on Influenza Vaccination Rates of a Telephone Text Message Recall From the Attending Physician
NCT06123936 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
NCT05313893 ·Status: COMPLETED ·Phase: PHASE4
-
Systems Investigation of Vaccine Responses in Aging and Frailty
NCT05291676 ·Status: RECRUITING ·Phase: PHASE2
-
Precision Vaccine Promotion in Underserved Populations
NCT05537441 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of an Adjuvanted Influenza Vaccine in Subjects Aged 65 Years and Over.
NCT00316628 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate the Safety, Tolerability and Immunogenicity of a Universal Influenza A Vaccine
NCT01265914 ·Status: COMPLETED ·Phase: PHASE1
-
Influenza A Vaccine (FP-01.1) Formulated With and Without Adjuvant, in the Presence or Absence of a Single Administration of a Trivalent Inactivated Influenza Virus Vaccine in Older Adults
NCT01701752 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2007/2008) When Administered to Elderly Subjects
NCT00522236 ·Status: COMPLETED ·Phase: PHASE2
-
The Safety and Immunogenicity Evaluation of Live Attenuated Influenza Vaccine
NCT05056519 ·Status: UNKNOWN ·Phase: PHASE1
-
Estimate the Safety and Effectiveness of Adjuvanted Influenza Vaccine Among Asian Elderly People When Compared to Non-adjuvanted Vaccines
NCT06676644 ·Status: RECRUITING ·Phase: NA
-
A Clinical Trial of an Inactivated Quadrivalent Influenza Vaccine in Chinese Children Aged 3 to 8 Years
NCT05144464 ·Status: UNKNOWN ·Phase: PHASE4
-
Improving Influenza Vaccination Rates in Nurses Through Text Message Reminders : a RCT
NCT02589574 ·Status: UNKNOWN ·Phase: NA
-
Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysaccharide Vaccine
NCT05471531 ·Status: COMPLETED ·Phase: PHASE4
-
Safety Study of Freeze-dried Live Attenuated Influenza Vaccine for Intranasal Administration in Chinese Adults Aged 3 Years and Older
NCT02665871 ·Status: UNKNOWN ·Phase: PHASE1
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Healthy Adults
NCT01776541 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity of a Commercially Available Influenza Vaccine (Formulation 2006/2007) When Administered to Elderly Subjects
NCT00329927 ·Status: COMPLETED ·Phase: PHASE2
-
Open-Label Influenza Vaccine Evaluation
NCT02872311 ·Status: COMPLETED ·Phase: NA